13F HOLDINGS REPORT
Qiming U.S. Ventures Management, LLC
Quarter ended Q3 2025 · Filed November 10, 2025 · Accession 0001909617-25-000004
Total Value
$55.6M
Positions
4
Other Managers
0
Confidential Omitted
No
Holdings (4)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | TOURMALINE BIO INC | 89157D105 | 741,691 | $35.5M | 63.76% |
| 2 | KORRO BIO INC | KRRO | 368,085 | $17.6M | 31.68% |
| 3 | JASPER THERAPEUTICS INC | JSPRW | 928,964 | $2.2M | 3.97% |
| 4 | KEZAR LIFE SCIENCES INC | KZR | 82,871 | $323,197 | 0.58% |